Quintiles files for $600M IPO

Quintiles made it official on Feb. 15, filing to raise up to $600 million in an IPO after months of rumors and speculation. Quintiles, in part, handles contract research and strategic planning services for medical device and diagnostics companies, and clinical trial testing services for drug makers. The North Carolina company reported a $2.77 billion equity value as of March 2012, Reuters reports. Bain Capital and TPG Capital back the company, including other private equity investors. Quintiles attracted Morgan Stanley, Barclays, and J.P. Morgan Chase as lead underwriters. Story

Suggested Articles

The Salt Lake City-based developer said its Logix Smart test is now available to be exported from Utah to countries requiring the CE Mark.

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.